Not applicableStudy completedNCT00460408What this trial is testingOcular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular DegenerationWho this might be right forMacular Degeneration Pfizer 501
Testing effectiveness (Phase 2)Study completedNCT01134055What this trial is testingDose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular DegenerationWho this might be right forMacular Degeneration GlaxoSmithKline 510
Not applicableUnknownNCT03433885What this trial is testingWenzhou Dry Age-related Macular Degeneration (AMD) Progression StudyWho this might be right forMacular Pigment Optical Density The Eye Hospital of Wenzhou Medical University 300
Testing effectiveness (Phase 2)Study completedNCT00344227What this trial is testingProspective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)Who this might be right forNeovascular Age-Related Macular Degeneration University of Miami 40
Large-scale testing (Phase 3)Study completedNCT00215670What this trial is testingStudy of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)Who this might be right forAge-Related Macular Degeneration Eyetech Pharmaceuticals 125
Testing effectiveness (Phase 2)Study completedNCT01849692What this trial is testingESBA1008 Microvolume StudyWho this might be right forExudative Age-Related Macular Degeneration Alcon Research 107
Post-approval studies (Phase 4)Looking for participantsNCT06875245What this trial is testingComparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment IntervalsWho this might be right forWet Age-related Macular Degeneration Faculty Hospital Kralovske Vinohrady 100
Not applicableStudy completedNCT00393692What this trial is testingFundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser OphthalmoscopyWho this might be right forAge-related Macular Degeneration University Hospital, Bonn 700
Testing effectiveness (Phase 2)Study completedNCT01414153What this trial is testingEfficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMDWho this might be right forExudative Age-related Macular Degeneration Lpath, Inc. 158
Testing effectiveness (Phase 2)Study completedNCT03626636What this trial is testingA Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular DegenerationWho this might be right forDry Age-related Macular Degeneration Allegro Ophthalmics, LLC 42
Not applicableStudy completedNCT04779398What this trial is testingAssociation of MPOD Values With Blue Light.Who this might be right forAge Related Macular Degeneration The University of Queensland 96
Not applicableStudy completedNCT00734487What this trial is testingAREDS 2 Ancillary Spectral Domain Optical Coherence Tomography StudyWho this might be right forAge Related Macular Degeneration Duke University 470
Not applicableLooking for participantsNCT04796545What this trial is testingPost-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular DegenerationWho this might be right forAMDAge-Related Macular Degeneration VisionCare, Inc. 76
Not applicableLooking for participantsNCT07308639What this trial is testingDATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.Who this might be right forNeovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO) Bayer 50,000
Not applicableEnded earlyNCT04935411What this trial is testingRussian Registry of Patients With nAMDWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 2,665
Early research (Phase 1)Study completedNCT04989699What this trial is testingStudy Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Ocular Therapeutix, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT00089830What this trial is testingA Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationWho this might be right forMacular Degeneration Genaera Corporation 120
Not applicableUnknownNCT03859245What this trial is testingPhotobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease PreventionWho this might be right forDiabetic Retinopathy (DR)Age-related Macular Degeneration (AMD)Mid-peripheral Drusen Formation+1 more Bristlecone Health, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01527500What this trial is testingIntravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)Who this might be right forGeographic AtrophyAge-related Macular Degeneration Novartis Pharmaceuticals 158
Not applicableUnknownNCT01174407What this trial is testingImplication of CD35, CD21 and CD55 in Exudative Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Rudolf Foundation Clinic 120